Search

Author/Creator Barnes, Jeffrey

3. Phase 2 trial of high‐dose rituximab with high‐dose cytarabine mobilization therapy and high‐dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non‐Hodgkin lymphoma. Issue 2 (9th September 2014)

Authors:
Chen, Yi‐Bin; Batchelor, Tracy; Li, Shuli; Hochberg, Ephraim; Brezina, Mark; Jones, Sooae; Del Rio, Candice; Curtis, Morgan; Ballen, Karen K.; Barnes, Jeffrey; Chi, Andrew S.; Dietrich, Jorg; Driscoll, Jessica; Gertsner, Elizabeth R.; Hochberg, Fred; LaCasce, Ann S.; McAfee, Steven L.; Spitzer, T...
Journal:
Cancer
Issue:
Volume 121:Issue 2(2015)
Page Start:
226
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase 2 trial of high‐dose rituximab with high‐dose cytarabine mobilization therapy and high‐dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non‐Hodgkin lymphoma. Issue 2 (9th September 2014)

Authors:
Chen, Yi‐Bin; Batchelor, Tracy; Li, Shuli; Hochberg, Ephraim; Brezina, Mark; Jones, Sooae; Del Rio, Candice; Curtis, Morgan; Ballen, Karen K.; Barnes, Jeffrey; Chi, Andrew S.; Dietrich, Jorg; Driscoll, Jessica; Gertsner, Elizabeth R.; Hochberg, Fred; LaCasce, Ann S.; McAfee, Steven L.; Spitzer, T...
Journal:
Cancer
Issue:
Volume 121:Issue 2(2015)
Page Start:
226
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗